PHOENIX response to new NHS England’s long term plan
PHOENIX response to new NHS England’s long term plan 16 Jan 2019

Steve Anderson, managing director of PHOENIX UK, has welcomed the publication of NHS England’s Long-Term Year Plan and renewed his call for the Government to…

Find out more…

Galderma selects PHOENIX in a new Reduced Wholesaler Model
Galderma selects PHOENIX in a new Reduced Wholesaler Model 14 Jan 2019

Galderma selects PHOENIX in a new Reduced Wholesaler Model We are delighted to inform you that Galderma have selected PHOENIX in a new Reduced Wholesaler agreement…

Find out more…

Venclyxto® (venetoclax) available through PHOENIX
Venclyxto® (venetoclax) available through PHOENIX 09 Jan 2019

Venclyxto® (venetoclax) available through PHOENIX Manufacturer ABBVIE has chosen PHOENIX as a distribution partner for its oncolytic treatment Venclyxto® (venetoclax) Products available: PIP…

Find out more…

PHOENIX announce growth strategy in Northern Ireland
PHOENIX announce growth strategy in Northern Ireland 20 Dec 2018

PHOENIX have announced the next stage of its growth strategy in Northern Ireland with the acquisition of a significantly larger medicines distribution depot in Belfast. The…

Find out more…

Customer Services Festive Opening Times
Customer Services Festive Opening Times 20 Dec 2018

With the Christmas and New Year period approaching, we would like to advise you of our opening and closing times for the Festive period, and…

Find out more…

GlaxoSmithKline UK Pharmaceuticals selects PHOENIX in new Reduced Wholesale Model distribution agreement
GlaxoSmithKline UK Pharmaceuticals selects PHOENIX in new Reduced Wholesale Model distribution agreement 01 Oct 2018

GSK UK Pharmaceuticals are changing the distribution model for medicines from the current Direct to Pharmacy model to a Reduced Wholesaler model, from 1st November…

Find out more…